18F-AIPF-1026 PET/CT for MAO-A related diseases in adults
Official title: Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease
Run by Tianjin Medical University · NCT07685860 · Data updated 2026-11-12
A PET/CT test using 18F-AIPF-1026 is being looked at to see if it can help diagnose primary and metastatic lesions in adults with MAO-A–related conditions like depression, anxiety, and heart injuries.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Tianjin Medical University Academic / other |
| Locations | 3 sites (Hefei, Anhui and 2 other locations) |
| Status | Recruiting |
| Started | June 25, 2026 |
| Main results expected | July 1, 2029 |
| Study ends | July 1, 2029 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT07685860 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with suspected, newly diagnosed, or previously treated depression or MAO-A–related conditions who are scheduled for MAO-A PET/CT and can provide informed consent.
✕Probably not a fit
Patients with non-malignant lesions, those who are pregnant, or those unable to consent may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates how well 18F-AIPF-1026 PET/CT detects MAO-A-related lesions by measuring uptake with SUVmax and calculating sensitivity, specificity, PPV, NPV, and accuracy. Participants include adults with suspected, newly diagnosed, or previously treated depression or other MAO-A–related conditions who are scheduled for MAO-A PET/CT. The study analyzes PET/CT images to determine diagnostic performance across different lesion types and clinical scenarios. Interventions are diagnostic imaging with 18F-AIPF-1026, and results will inform potential utility for diagnosis and management. The investigation is led by Tianjin Medical University with multiple collaborating centers in China.
Why it matters
Potential benefit: If successful, the test could improve accuracy of detecting MAO-A–related lesions and aid in diagnosis and management.
How similar studies have gone: Previous work with MAO-A PET tracers has shown encouraging diagnostic performance in related settings, but this specific tracer and disease scope are relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated depression (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled MAO-A PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee. Exclusion Criteria: \- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Where it's running
-
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China Recruiting -
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China Recruiting -
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China Recruiting
Study contacts
- Study coordinator: Ying Wang, MD
- Email: macrossplusvoices@163.com
- Phone: +8618702292537
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
-
An Ultra-Brief ICBT Intervention with Personal Feedback for Depression and Anxiety
This trial tests whether adding personalized feedback about a person’s recent healthy actions to the Things You Do ultra-brief online CBT program helps adults with depression and anxiety do more healthy activities and feel better.
-
Virtual nature vs guided imagery for anxiety and well-being in hospitalized older adults
In this study, hospitalized adults 65 and older try two ways to bring nature to them: watching 360-degree nature videos on a VR headset or listening to a guided imagery audio to imagine the same scenes, to see which helps mood and anxiety during a two-week period.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.